Sentinel lymph node biopsy in thick malignant melanoma: A 10-year single unit experience

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 65, Issue 10, 2012, Pages 1396-1402

  Fairbairn, Neil G ^a   Orfaniotis, Georgios ^a   Butterworth, Mark ^a  

^a ST JOHN'S HOSPITAL   (United Kingdom)

Author keywords

Sentinel lymph node biopsy; Survival; Thick melanoma

Indexed keywords

ADULT; AGED; ARTICLE; BRESLOW THICKNESS; CANCER RECURRENCE; CANCER SURGERY; CLARK LEVEL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFORMED CONSENT; LIMB; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTATIC MELANOMA; MITOSIS; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR LOCALIZATION; TUMOR VOLUME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84866413139     PISSN: 17486815     EISSN: 18780539     Source Type: Journal    
DOI: 10.1016/j.bjps.2012.04.019     Document Type: Article

References (22)

1. D.L. Morton, A.J. Cochrane, and J.F. Thompson Sentinel lymph node biopsyfor early stage melanoma: accuracy and morbidity in MSLT-1, an international multi-centre trial Ann Surg 242 2005 302 311
2. J.E. Gershenwald, W. Thomson, and P.F. Mansfield Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel node status in 612 stage I or II melanoma patients J Clin Oncol 17 3 1999 976 983
3. J.F. Thompson, and H.M. Shaw The prognosis of patients with thick primary melanoma: is regional lymph node status relevant, and does removing positive regional nodes influence outcome? Ann Surg Oncol 9 8 2002 719 722
4. R. Gutzmer, M. Al Ghazal, and H. Geerlings Sentinel lymph node biopsy in melanoma delays recurrence but does not change melanoma related survival: a retrospective analysis of 673 patients Br J Dermatol 153 2005 1137 1141
5. J.E. Gershenwald, P.F. Mansfield, and J.E. Lee Role for lymphatic mapping and seninel lymph node biopsy in patients with thick (≥4 mm) primary melanoma Ann Surg Oncol 7 2 2000 160 165
6. I.A. Jacobs, C.K. Chang, and G.I. Salti Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanoma Am Surg 70 1 2004 59 62
7. G.W. Carlson, D.R. Murray, and A. Hestley Sentinel lymph node mapping for thick (≥4 mm) melanoma: should we be doing it? Ann Surg Oncol 10 4 2003 408 415
8. C. Gajdos, K.A. Griffith, and S.L. Wong Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer 115 24 2009 5752 5760
9. S.C. Paek, K.A. Griffith, and T.M. Johnson The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma Cancer 109 2007 100 108
10. L.L. Kruper, F.R. Spitz, and B.J. Czerniecki Predicting sentinel node status in AJCC stage 1/11 primary cutaneous melanoma Cancer 107 2006 2436 2445
11. C.L. Nguyen, E.F. McClay, and D.J. Cole Melanoma thickness and histology predict sentinel lymph node status Am J Surg 181 2001 8 11
12. B.M. Clary, M.S. Brady, and J.J. Lewis Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence Ann Surg 233 2 2001 250 258
13. J.F. Thomson, and H.M. Shaw Should tumour mitotic rate and patient age, as well as tumour thickness, be used to elect melanoma patients for sentinel lymph node biopsy? Ann Surg Oncol 11 3 2004 233 235
14. C.M. Balch, J.E. Gershenwald, and S.J. Soong Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 36 2009 6199 6206
15. C.M. Balch, J.E. Gershenwald, and S.J. Soong Multivariate analysis of prognosptic factors among 2313 patients with stage II melanoma: comparison of nodal micrometastases versus macrometastases J Clin Oncol 28 14 2010 2452 2459
16. F. Rondelli, M. Vedovati, and C. Becattini Prognostic role sentinel lymph node biopsy patient thick melanoma a meta-analysis J Eur Acad Dermatol Venereol 2011 [Epub ahead of print]
17. A.N. Meguerditchian, K. Asubonteng, and C. Young Thick primary melanoma has a heterogenous tumour biology: an institutional series World J Surg Oncol 9 2011 Apr 14 40
18. C.R. Scoggins, A.L. Bowen, and R.C. Martin Prognostic information from sentinel lymph node biopsy in patients with thick melanoma 2nd Arch Surg 145 7 2010 Jul 622 627
19. D.L. Morton, J.F. Thompson, and A.J. Cochran Sentinel-node biopsy or nodal observation in melanoma N Eng J Med 355 13 2006 Sep 28 1307 1317
20. R. Essner, M.H. Chung, and R. Bleicher Prognostic implications of thick (≥4 mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy Ann Surg Oncol 9 8 2002 754 761
21. R. Essner, A. Conforti, and M.C. Kelly Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early stage melanoma Ann Surg Oncol 6 5 1999 442 449
22. Z.I. Nowecki, P. Rutkowski, and A. Nasierowska-Guttmejer Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma Ann Surg Oncol 13 12 2006 Dec 1655 1663